Showing results (211-220 of 632) with videos related to
Sort By:
Pageof 64
Human Vaccines|October 3, 2006
Maturation of recombinant hepatitis B virus surface antigen particlesQinjian Zhao, Yang Wang, Daniel Freed, et al.Human Vaccines|October 3, 2006
Dose-response relationship of DNA and recombinant fowlpox virus prime-boost HIV vaccines: implications for future trialsRobert De Rose, Mark T Sullivan, C Jane Dale, et al.Human Vaccines|October 3, 2006
A pilot study of SRL 172 (killed Mycobacterium vaccae) in healthy chronic hepatitis B carriers and hepatitis B vaccine non-respondersPaul N GoldwaterHuman Vaccines|October 3, 2006
Cancer vaccines targeting carbohydrate antigensPhilip O Livingston, Govind RagupathiHuman Vaccines|October 3, 2006
Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen (FALVAC-1A) expressed in Escherichia coliZhiyong Zhou, Charles W Todd, Robert M Wohlhueter, et al.Human Vaccines|November 15, 2006
Reactogenicity of meningococcal C conjugate vaccines when administered at the same time as, or a month prior to or after, tetanus and diphtheria booster vaccinationsJo Southern, David Gelb, Nick Andrews, et al.Human Vaccines|October 14, 2006
Delivering pneumococcal vaccine to a high risk population: the Navajo experienceAndrea L Benin, James P Watt, Katherine L O'Brien, et al.Human Vaccines|October 14, 2006
A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvantsHelvi Holm Samdal, Hilde Bakke, Fredrik Oftung, et al.Human Vaccines|October 14, 2006
Exercise-induced serum enzyme elevations confounding the evaluation of investigational drug toxicity. Report of two cases in a vaccine trialCasey Johnson, Thomas P Monath, Niranjan Kanesa-Thasan, et al.Human Vaccines|October 14, 2006
Role of neutralizing antibodies in protective immunity against HIVIndresh K Srivastava, Jeffrey B Ulmer, Susan W BarnettPageof 64